VRCA

Q: What is the price of Verrica Pharmaceuticals (VRCA) today?

A cotação de Verrica Pharmaceuticals (VRCA) hoje está em $ 8.43, com uma variação de The stock began the year trading around $ 8.31 and is currently priced at $ 8.43. negociando na casa dos $ 8.31 e hoje está em $ 8.43. Acompanhe o and track broader market trends directly on the platform.

Q: When does Verrica Pharmaceuticals (VRCA) pay dividends?

Verrica Pharmaceuticals (VRCA) did not pay dividends over the past year.

Q: Is Verrica Pharmaceuticals (VRCA) a good investment?

Atualmente, Verrica Pharmaceuticals (VRCA) está cotada a $ 8.43, com um P/L de -4.91, This represents a -2,492% premium compared to its historical average P/E. uma variação de 87.25 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 87.25%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Verrica Pharmaceuticals Inc.

Price

$ 8.43

return (12m)

87.25%

p/e

-4.91

p/bv

3.55

DIVIDEND YIELD

0.00%

VRCA price

VRCA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment VRCA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

40.97%

3 months

27.53%

1 year

87.25%

2 years

-88.47%

5 years

-92.67%

10 years

0.00%

Fundamentals VRCA

review the fundamentals of Verrica Pharmaceuticals shares

P/E

-4.91

Sector: -2.06 Industry: -5.69

P/S (PSR)

2.47

Sector: 1.92 Industry: 2.91

P/BV

3.55

Sector: 2.15 Industry: 2.10

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-37.94%

Sector: -26.18% Industry: -48.72%

ROE

-72.27%

Sector: -30.04% Industry: -41.60%

ROIC

-119.70%

Sector: -416.85% Industry: -485.31%

NET MARGIN

-50.27%

Sector: -28.27% Industry: -32.26%

GROSS MARGIN

90.33%

Sector: 44.63% Industry: 45.25%

OPERATING MARGIN

-33.57%

Sector: -23.33% Industry: -27.86%

EV/EBITDA

-9.16

Sector: -0.50 Industry: -2.94

EV/EBIT

-8.66

Sector: -1.98 Industry: -4.96

PRICE-TO-ASSETS

1.86

Sector: 1.16 Industry: 1.33

BVPS

1.77

Sector: 3.80 Industry: 2.15

EPS

-1.28

Sector: -0.90 Industry: -1.33

EQUITY-TO-ASSETS RATIO

0.52

Sector: 0.44 Industry: 0.49

LIABILITIES / ASSETS

0.48

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

24.27%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-12.61%

Sector: - Industry: -

Fundamentals VRCA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	34.11	27.64	81.01%	0.65%	$ 862.18 B	34.98%
ISRG	54.55	9.24	16.93%	0.00%	$ 162.51 B	28.15%
TMO	25.49	3.35	13.15%	0.38%	$ 174.55 B	15.15%
SNY	12.33	1.34	10.86%	4.80%	$ 112.48 B	18.68%
NVS	20.68	7.19	34.77%	2.12%	$ 279.88 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	22.25	2.09	9.38%	3.55%	$ 102.64 B	13.00%
GSK	13.24	4.47	33.77%	3.40%	$ 103.84 B	17.79%
CVS	58.97	1.38	2.35%	3.24%	$ 104.25 B	0.44%
BSX	23.54	0.00	0.00%	0.00%	$ 83.90 B	17.29%
TMDX	17.87	7.19	40.22%	0.00%	$ 3.40 B	31.43%
HCA	14.28	-32.58	-228.14%	0.68%	$ 97.01 B	8.89%
IDXX	42.85	28.28	65.99%	0.00%	$ 45.40 B	24.62%
RMD	19.56	4.58	23.41%	1.14%	$ 29.73 B	27.44%
DHR	33.62	2.34	6.97%	0.78%	$ 124.01 B	14.89%
INMD	9.68	1.33	13.73%	0.00%	$ 907.83 M	25.32%
PHG	23.98	1.93	8.06%	3.39%	$ 24.88 B	5.07%
SYK	34.78	5.03	14.48%	1.17%	$ 112.88 B	12.92%
FMS	11.40	0.77	6.75%	3.50%	$ 12.86 B	5.02%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

VRCA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2018

Time since IPO - 8 years

29

Employees

Verrica Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $87.78 Millions, with shareholders equity totaling $24.74 Millions.

The company employs approximately 29 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Verrica Pharmaceuticals Inc. reported $35.57 Millions in revenue, generating net income of $-17.88 Millions.

Key financial metrics include a P/E ratio of -4.91, a price-to-book (P/B) ratio of 3.55, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VRCA.

Market cap

$ 87.78 Millions

Net worth

$ 24.74 Millions

$ 24,740,000.00

Assets

$ 47.13 Millions

$ 47,130,000.00

Total Shares Outstanding

14.00 Millions

14,000,000

Average Daily Trading Volume

$ 106.23 Thousand

$ 106,233.44

Sector

Health

Industry

Pharmaceutical Products

VRCA

VRCA revenue and profits

Financial Results VRCA

DRAG THE FRAME TO SEE MORE DATA

VRCA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 86.86 34,83% (12M)

P/E

58.97

3.24%

ROE

2.35%

P/BV

1.38

CI - Cigna

$ 281.98 --13,42% (12M)

P/E

10.33

2.15%

ROE

16.97%

P/BV

1.75

CNC - Centene

$ 55.31 --12,09% (12M)

P/E

-4.07

0.00%

ROE

-29.93%

P/BV

1.22

HUM - Humana

$ 246.33 --0,74% (12M)

P/E

24.81

1.52%

ROE

6.06%

P/BV

1.50

LLY - Eli Lilly

$ 987.05 32,31% (12M)

P/E

34.11

0.65%

ROE

81.01%

P/BV

27.64

HCA - HCA Healthcare

$ 429.45 19,98% (12M)

P/E

14.28

0.68%

ROE

-228.14%

P/BV

-32.58

NVS - Novartis

$ 148.34 35,40% (12M)

P/E

20.68

2.12%

ROE

34.77%

P/BV

7.19